A
Menu
First published March 19, 2020 Application Aachen patent C – Chemistry & metallurgy

MUSK ACTIVATION

Espacenet Family 68138767

Abstract

Novel methods for treating a condition or disorder associated with impaired neuromuscular transmission,such as MuSK myasthenia gravis(MuSK MG), in a subject are provided herein. Novel methods for treating a symptom associated with impaired neuromuscular transmission in a subject are also provided. The invention also provides multivalent binding agents for use in treating the same.

Inventors 4

  1. Silvère M. van der Maarel Aachen author as filed: van der Maarel, Silvère Maria
  2. J. Verschuuren Aachen author as filed: Verschuuren, Johannes Justus Gerard Maria
  3. M. Huijbers Aachen author as filed: Huijbers, Martina Gerardina Maria
  4. Plomp, Jakob Jan

Inventors are linked to an Aachen author when surname and first name match exactly one author.

Applicants

  • ACADEMISCH ZIEKENHUIS LEIDEN (H.O.D.N. LUMC) GBS Leiden

Cited papers 12 in the database

Non-patent literature as cited (73)
  • - LABRIJN, NATURE PROTOCOLS, 2014
  • - HUIJBERSZHANG ET AL., PNAS, 2013
  • - VAN DER NEUT KOLFSCHOTEN ET AL., SCIENCE, vol. 317, 2007, pages 1554 - 1557
  • - JONSSON, U. ET AL., BIOTECHNIQUES, vol. 11, 1991, pages 620 - 627
  • - CHOTHIALESK, J. MOL. BIOL., vol. 196, 1987, pages 901 - 917
  • - NEEDLEMAN ET AL., J. MOL. BIOL., vol. 48, 1970, pages 444 - 453
  • - MEYERS ET AL., CABIOS, vol. 4, 1989, pages 11 - 17
  • - JONSSON, U. ET AL., ANN. BIOL. CLIN., vol. 51, 1993, pages 19 - 26
  • - JOHNSSON, B. ET AL., J. MOL. RECOGNIT., vol. 8, 1995, pages 125 - 131
  • - JOHNNSON, B. ET AL., ANAL. BIOCHEM., vol. 198, 1991, pages 268 - 277
  • - "UniprotKB", Database accession no. 015146
  • - MORRISON, S. L. ET AL., PROC. NATL. ACAD SCI. USA, vol. 81, 1984, pages 6851 - 6855
  • - RIECHMANN, L. ET AL., NATURE, vol. 332, 1988, pages 323 - 327
  • - NEUBERGER, M. S. ET AL., NATURE, vol. 314, 1985, pages 268 - 270
  • - LEFRANC, M.-P., CURRENT PROTOCOLS IN IMMUNOLOGY, 2000, pages 37
  • - VAN DIJK, M. A.VAN DE WINKEL, J. G., CURR. OPIN. CHEM. BIOL., vol. 5, 2001, pages 368 - 374
  • - JAKOBOVITS, A. ET AL., PROC. NATL. ACAD. SCI. USA, vol. 90, 1993, pages 2551 - 2555
  • - JAKOBOVITS, A. ET AL., NATURE, vol. 362, 1993, pages 255 - 258
  • - BRUEGGEMANN, M. D. ET AL., YEAR IMMUNOL., vol. 7, 1993, pages 33 - 40
  • - HOOGENBOOM, H. R.WINTER, G., J. MOL. BIOL., vol. 227, 1992, pages 381 - 388
  • - MARKS, J. D. ET AL., J. MOL. BIOL., vol. 222, 1991, pages 581 - 597
  • - COLE, A. ET AL.: "Monoclonal Antibodies and Cancer Therapy", 1985, MACK PUBLISHING COMPANY, pages: 77
  • - BOERNER, P. ET AL., J. IMMUNOL., vol. 147, 1991, pages 86 - 95
  • - BIRD ET AL., SCIENCE, vol. 242, 1988, pages 423 - 426
  • - HUSTON ET AL., PROC. NATL. ACAD. SCI. U.S.A., vol. 85, 1988, pages 5879 - 5883
  • - HU ET AL., CANCER RES., vol. 56, 1996, pages 3055 - 3061
  • - CHAMOW ET AL., TRENDS BIOTECHNOL, vol. 14, 1996, pages 52 - 60
  • - ASHKENAZI ET AL., CURROPIN IMMUNOL, vol. 9, 1997, pages 195 - 200
  • - HUSTON, J. S., METHODS IN ENZYMOL., vol. 203, 1991, pages 46 - 88
  • - KHAW, B. A. ET AL., J. NUCL. MED., vol. 23, 1982, pages 1011 - 1019
  • - SCHUURMAN ET AL., MABS, vol. 121, no. 6, November 2012 (2012-11-01), pages 636 - 636
  • - AALBERSE ET AL., INT ARCH ALLERGY IMMUNOL, vol. 118, 1999, pages 187 - 189
  • - LABRIJN ET AL., NAT BIOTECHNOL, vol. 27, 2009, pages 767 - 771
  • - SCHUURMAN ET AL., MOL IMMUNOL, vol. 38, 2001, pages 1 - 8
  • - MAKARAVICIUTE AJACKSON CDMILLNER PARAMANAVICIENE A, J IMMUNOL METHODS, vol. 429, February 2016 (2016-02-01), pages 50 - 6
  • - EDELMAN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 63, no. 1, 1969, pages 78 - 85
  • - BLOOM ET AL., PROTEIN SCI, vol. 6, 1997, pages 407 - 415
  • - ANGAL ET AL., MOLECULAR IMMUNOLOGY, vol. 30, no. 1, 1993, pages 105 - 108
  • - STUBENRAUCH ET AL., DRUG METAB DISPOS, vol. 38, 2010, pages 84 - 91
  • - ENGEL, HANDB CLIN NEUROL, vol. 91, 2008, pages 285 - 331
  • - N ENGL J MED., vol. 375, no. 6, 11 August 2016 (2016-08-11), pages 511 - 22
  • - SINGLETONSAINSBURY: "Dictionary of Microbiology and Molecular Biology", 1991, JOHN WILEY AND SONS
  • - VAN DE BOVENKAMP FSDERKSEN NILOOIJEVAAR-DE HEER PVAN SCHIE KAKRUITHOF SBERKOWSKA MAVAN DER SCHOOT CEIJSPEERT HVAN DER BURG MGILS A: "Adaptive antibody diversification through N-linked glycosylation of the immunoglobulin variable region", PROC NATL ACAD SCI USA., vol. 115, no. 8, 20 February 2018 (2018-02-20), pages 1901 - 1906
  • - BURDEN SJYUMOTO NZHANG W: "The role of MuSK in synapse formation and neuromuscular disease", COLD SPRING HARB PERSPECT BIOL., vol. 5, no. 5, 1 May 2013 (2013-05-01), pages a009167
  • - BURDEN SJHUIJBERS MGREMEDIO L: "Fundamental Molecules and Mechanisms for Forming and Maintaining Neuromuscular Synapses", LNT J MOL SCI., vol. 19, no. 2, 6 February 2018 (2018-02-06)
  • - EVOLI ATONALI PAPADUA LMONACO MLSCUDERI FBATOCCHI APMARINO MBARTOCCIONI E: "Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis", BRAIN, vol. 126, October 2003 (2003-10-01), pages 2304 - 11
  • - HESSER BAHENSCHEL OWITZEMANN V: "Synapse disassembly and formation of new synapses in postnatal muscle upon conditional inactivation of MuSK", MOL CELL NEUROSCI., vol. 31, no. 3, March 2006 (2006-03-01), pages 470 - 80, XP024908215, doi:10.1016/j.mcn.2005.10.020
  • - HOCH WMCCONVILLE JHELMS SNEWSOM-DAVIS JMELMS AVINCENT A: "Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies", NAT MED., vol. 7, no. 3, March 2001 (2001-03-01), pages 365 - 8, XP002183364, doi:10.1038/85520
  • - HUIJBERS MGVINK AFNIKS EHWESTHUIS RHVAN ZWET EWDE MEEL RHROJAS-GARCIA RDIAZ-MANERA JKUKS JBKLOOSTER R: "Longitudinal epitope mapping in MuSK myasthenia gravis: implications for disease severity", J NEUROIMMUNOL., vol. 291, 15 February 2016 (2016-02-15), pages 82 - 8
  • - HUIJBERS MGZHANG WKLOOSTER RNIKS EHFRIESE MBSTRAASHEIJM KRTHIJSSEN PEVROLIJK HPLOMP JJVOGELS P: "MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4", PROC NATL ACAD SCI USA., vol. 110, no. 51, 17 December 2013 (2013-12-17), pages 20783 - 8
  • - KLOOSTER RPLOMP JJHUIJBERS MGNIKS EHSTRAASHEIJM KRDETMERS FJHERMANS PWSLEIJPEN KVERRIPS ALOSEN M: "Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice", BRAIN, vol. 135, April 2012 (2012-04-01), pages 1081 - 101
  • - KONECZNY ICOSSINS JWATERS PBEESON DVINCENT A: "MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters", PLOS ONE, vol. 8, no. 11, 7 November 2013 (2013-11-07), pages e80695
  • - KONECZNY ISTEVENS JADE ROSA AHUDA SHUIJBERS MGSAXENA AMAESTRI MLAZARIDIS KZISIMOPOULOU PTZARTOS S: "lgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients", J AUTOIMMUN., vol. 77, February 2017 (2017-02-01), pages 104 - 115, XP029897113, doi:10.1016/j.jaut.2016.11.005
  • - KONING MTKIETBASA SMBOERSMA VBUERMANS HPJVAN DER ZEEUW SAJVAN BERGEN CAMCLEVEN AHGKLUIN PMGRIFFIOEN MNAVARRETE MA: "ARTISAN PCR: rapid identification of full-length immunoglobulin rearrangements without primer binding bias", BR J HAEMATOL., vol. 178, no. 6, September 2017 (2017-09-01), pages 983 - 986
  • - LIGHAAM LCRISPENS T: "The Immunobiology of Immunoglobulin G4", SEMIN LIVER DIS., vol. 36, no. 3, August 2016 (2016-08-01), pages 200 - 15
  • - LIGHAAM LCVERMEULEN EBLEKER TDMEIJLINK KJAALBERSE RCBARNES ECULVER ELVAN HAM SMRISPENS T: "Phenotypic differences between gG4+ and gG1+ B cells point to distinct regulation of the IgG4 response", J ALLERGY CLIN IMMUNOL., vol. 133, no. 1, January 2014 (2014-01-01), pages 267 - 70.e1,6
  • - MCCONVILLE JFARRUGIA MEBEESON DKISHORE UMETCALFE RNEWSOM-DAVIS JVINCENT A: "Detection and characterization of MuSK antibodies in seronegative myasthenia gravis", ANN NEUROL., vol. 55, no. 4, April 2004 (2004-04-01), pages 580 - 4
  • - VAN DER NEUT KOLFSCHOTEN MSCHUURMAN JLOSEN MBLEEKER WKMARTINEZ-MARTINEZ PVERMEULEN EDEN BLEKER THWIEGMAN LVINK TAARDEN LA: "Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange", SCIENCE, vol. 317, no. 5844, 14 September 2007 (2007-09-14), pages 1554 - 7, XP009104480, doi:10.1126/science.1144603
  • - OTSUKA KITO MOHKAWARA BMASUDA AKAWAKAMI YSAHASHI KNISHIDA HMABUCHI NTAKANO AENGEL AG: "Collagen Q and anti-MuSK autoantibody competitively suppress agrin/LRP4/MuSK signaling", SCI REP., vol. 5, 10 September 2015 (2015-09-10), pages 13928
  • - STIEGLER ALBURDEN SJHUBBARD SR: "Crystal structure of the agrin-responsive immunoglobulin-like domains 1 and 2 of the receptor tyrosine kinase MuSK", J MOL BIOL., vol. 364, no. 3, 1 December 2006 (2006-12-01), pages 424 - 33, XP024950703, doi:10.1016/j.jmb.2006.09.019
  • - ZHANG WCOLDEFY ASHUBBARD SRBURDEN SJ: "Agrin binds to the N-terminal region of Lrp4 protein and stimulates association between Lrp4 and the first immunoglobulin-like domain in muscle-specific kinase (MuSK", J BIOL CHEM., vol. 286, no. 47, 25 November 2011 (2011-11-25), pages 40624 - 30
  • - SARAH CANTOR ET AL: "Preserving neuromuscular synapses in ALS by stimulating MuSK with a therapeutic agonist antibody", ELIFE, vol. 7, 20 February 2018 (2018-02-20), XP055587207, DOI: 10.7554/eLife.34375
  • - MORI SHUUICHI ET AL: "Divalent and monovalent autoantibodies cause dysfunction of MuSK by distinct mechanisms in a rabbit model of myasthenia gravis", JOURNAL OF NEUROIMMUNOLOGY, vol. 244, no. 1, 1 January 2012 (2012-01-01), pages 1 - 7, XP028903355, ISSN: 0165-5728, DOI: 10.1016/J.JNEUROIM.2011.12.005
  • - KONECZNY INGA ET AL: "IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients", JOURNAL OF AUTOIMMUNITY, LONDON, GB, vol. 77, 10 December 2016 (2016-12-10), pages 104 - 115, XP029897113, ISSN: 0896-8411, DOI: 10.1016/J.JAUT.2016.11.005
  • - JAN J.G.M. VERSCHUUREN ET AL: "Passive transfer models of myasthenia gravis with muscle-specific kinase antibodies : MuSK MG passive transfer", ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, vol. 1413, no. 1, 21 January 2018 (2018-01-21), US, pages 111 - 118, XP055587218, ISSN: 0077-8923, DOI: 10.1111/nyas.13543
  • - MAARTJE G. HUIJBERS ET AL: "IgG4-mediated autoimmune diseases: a niche of antibody-mediated disorders : IgG4-mediated autoimmune diseases", ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, vol. 1413, no. 1, 28 January 2018 (2018-01-28), US, pages 92 - 103, XP055587211, ISSN: 0077-8923, DOI: 10.1111/nyas.13561
  • - MASAHARU TAKAMORI: "Structure and function of neuromuscular junction, centered on muscle-specific tyrosine kinase and related proteins", CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, vol. 7, no. 3, 1 August 2016 (2016-08-01), pages 215 - 225, XP055587248, ISSN: 1759-1961, DOI: 10.1111/cen3.12314
  • - MAARTJE G. HUIJBERS ET AL: "MuSK myasthenia gravis monoclonal antibodies : Valency dictates pathogenicity", NEUROLOGY - NEUROIMMUNOLOGY NEUROINFLAMMATION, vol. 6, no. 3, 21 February 2019 (2019-02-21), pages e547, XP055585991, DOI: 10.1212/NXI.0000000000000547
  • - Hubbard SR, Gnanasambandan K. Structure and activation of MuSK, a receptor tyrosine kinase central to neuromuscular junction formation. Biochim Biophys Acta. 2013 Oct;1834(10):2166-9. doi: 10.1016/j.bbapap.2013.02.034. Epub 2013 Mar 5. PMID: 23467009; PMCID: PMC3923368. (Year: 2013)
  • - Lim JL. Development and characterization of agonistic antibodies targeting the Ig-like 1 domain of MuSK. Sci Rep. 2023 May 8;13(1):7478. doi: 10.1038/s41598-023-32641-1. PMID: 37156800; PMCID: PMC10167245. (Year: 2023)
  • - Gershoni JM, Roitburd-Berman A, Siman-Tov DD, Tarnovitski Freund N, Weiss Y. Epitope mapping: the first step in developing epitope-based vaccines. BioDrugs. 2007;21(3):145-56. doi: 10.2165/00063030-200721030-00002. PMID: 17516710; PMCID: PMC7100438. (Year: 2007)
  • - Blythe MJ, Flower DR. Benchmarking B cell epitope prediction: underperformance of existing methods. Protein Sci. 2005 Jan;14(1):246-8. doi: 10.1110/ps.041059505. Epub 2004 Dec 2. PMID: 15576553; PMCID: PMC2253337. (Year: 2004)
  • - Schreiber A, Humbert M, Benz A, Dietrich U. 3D-Epitope-Explorer (3DEX): localization of conformational epitopes within three-dimensional structures of proteins. J Comput Chem. 2005 Jul 15;26(9):879-87. doi: 10.1002/jcc.20229. PMID: 15834923. (Year: 2005)

Cited patents 8

WO9721811A2 US5202238A US5204244A WO03011161A1 US7267820B2 WO2013074636A1 WO2015039015A2 US2006177441A1